Global Regadenoson Market Projected to Attain USD 2.1 Billion Valuation by 2035 | Rising at 8.6% CAGR (2025–2035)
The Regadenoson Market represents a specialized and rapidly expanding segment within the global cardiovascular diagnostic pharmaceuticals landscape. Regadenoson is a selective A2A adenosine receptor agonist primarily used as a pharmacologic stress agent in myocardial perfusion imaging (MPI) to evaluate coronary artery disease … Read more